Investing.com - Financial Markets Worldwide

Galmed Pharmaceuticals Ltd (GLMD)

NASDAQ
Currency in USD
2.930
+0.140(+5.02%)
Closed
Pre Market
2.900-0.030(-1.02%)

GLMD Balance Sheet

Advanced Balance Sheet
Collapse All
Period Ending:
2014
31/12
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
Total Current Assets
aa.aaaa.aaaa.aaaa.aaaa.aa76.4351.8136.0514.7213.24
Cash And Equivalents
Cash And Equivalents Growth
Short Term Investments
Total Receivables
Accounts Receivable, Total
Other Receivables
Inventory
Prepaid Expenses
Finance Division Loans and Leases Current
Finance Division Other Current Assets, Total
Other Current Assets
Restricted Cash
Other Current Assets, Total
Total Assets
aa.aaaa.aaaa.aaaa.aaaa.aa77.1452.3836.6116.5616.63
Total Assets Growth
Net Property Plant And Equipment
Gross Property Plant And Equipment
Accumulated Depreciation
Long-term Investments
Intangible Assets
Goodwill
Other Intangibles, Total
Finance Division Loans and Leases Long-Term
Other Assets, Total
Loans Receivable Long-Term
Accounts Receivable Long-Term
Deferred Tax Assets Long-Term
Deferred Charges Long-Term
Other Long-Term Assets, Total
Total Current Liabilities
aa.aaaa.aaaa.aaaa.aaaa.aa6.938.015.883.092.75
Accounts Payable, Total
Accrued Expenses, Total
Short-term Borrowings
Current Portion of Long-Term Debt / Leases
Current Portion of Long-Term Debt
Current Portion of Leases
Other Current Liabilities, Total
Current Income Taxes Payable
Unearned Revenue Current, Total
Other Current Liabilities
Total Liabilities
aa.aaaa.aaaa.aaaa.aaaa.aa7.298.236.113.142.75
Total Liabilities Growth
Long-Term Debt
Long-Term Leases
Other Liabilities, Total
Unearned Revenue Non Current
Pension & Other Post Retirement Benefits
Deferred Tax Liability Non Current
Other Non Current Liabilities